Medicines and Healthcare products Regulatory Agency
1: Authorisation Number | UK MIA 55591 |
---|---|
2: Name of authorisation holder | CALITA NUTRACEUTICALS LTD |
3: Address(es) of manufacturing site(s) |
CALITA NUTRACEUTICALS LTD, UNIT 1B GREAT CENTRAL INDUSTRIAL ESTATE, GREAT CENTRAL WAY, RUGBY, CV21 3XH, UNITED KINGDOM |
4: Legally registered address of authorisation holder | CALITA NUTRACEUTICALS LTD, UNIT 1B GREAT CENTRAL INDUSTRIAL ESTATE, GREAT CENTRAL WAY, RUGBY, CV21 3XH, UNITED KINGDOM |
5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 |
6: Legal Basis of authorisation | |
7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential |
8: Authorisation Date | 26/08/2022 |
9: Annexes attached | Annex 1 and/or Annex 2 |
SCOPE OF AUTHORISATION
Annex 1
Name and address of the site:
CALITA NUTRACEUTICALS LTD, UNIT 1B GREAT CENTRAL INDUSTRIAL ESTATE, GREAT CENTRAL WAY, RUGBY, CV21 3XH, UNITED KINGDOM
Human Medicinal Products
Authorised Operations |
MANUFACTURING OPERATIONS (according to part 1) |
Part 1 - MANUFACTURING OPERATIONS |
[ 1.2 ] Non-sterile products |
[ 1.2.1 ] Non-Sterile Products (processing operations for the following dosage forms) |
[ 1.2.1.1 ] Capsules, hard shell |
[ 1.2.1.8 ] Other solid dosage forms |
[ 1.2.1.13 ] Tablets |
[ 1.4 ] Other products or manufacturing activity |
[ 1.4.1 ] Manufacture of: |
[ 1.4.1.1 ] Herbal products |
[ 1.5 ] Packaging |
[ 1.5.1 ] Primary packaging |
[ 1.5.1.1 ] Capsules, hard shell |
[ 1.5.1.2 ] Capsules, soft shell |
[ 1.5.1.8 ] Other solid dosage forms |
[ 1.5.1.13 ] Tablets |
[ 1.5.2 ] Secondary packaging |